Literature DB >> 9329970

Pertussis toxin-sensitive G proteins as mediators of the signal transduction pathways activated by cytomegalovirus infection of smooth muscle cells.

T Shibutani1, T M Johnson, Z X Yu, V J Ferrans, J Moss, S E Epstein.   

Abstract

We demonstrated recently that the arachidonic acid (AA) cascade is involved in cytomegalovirus (CMV)-induced generation of reactive oxygen species (ROS) and the activation of nuclear factor (NF)-kappaB in human smooth muscle cells (SMCs). Since AA release from neutrophils is mediated by pertussis toxin (PTx)-sensitive guanine nucleotide-binding (G) proteins, we hypothesized by analogy that CMV stimulates ROS generation in SMCs and ultimately activates NF-kappaB via a PTx-sensitive G protein-coupled pathway. Our first test of this hypothesis demonstrated that PTx blocked AA release induced by CMV infection of SMCs, as well as blocked the terminal products of this reaction, ROS generation and NF-kappaB activation. More proximal components of the pathway were then examined. CMV infection increased phosphorylation and activity of cytosolic phospholipase A2 (cPLA2), an enzyme causing AA release; these effects were inhibited by PTx. CMV infection activated mitogen-activated protein (MAP) kinase, a key enzyme for cPLA2 phosphorylation, an effect also inhibited by PTx. Finally, inhibition of MAP kinase kinase (MAPKK), which phosphorylates and thereby activates MAP kinase, inhibited CMV-induced ROS generation. These data demonstrate that a PTx-sensitive G protein-dependent signaling pathway mediates cellular effects of CMV infection of SMCs. The downstream events include phosphorylation and activation of MAP kinase by MAPKK and subsequent phosphorylation and activation of cPLA2 (with its translocation to cell membranes), followed by stimulation of the AA cascade, which generates intracellular ROS and thereby activates NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9329970      PMCID: PMC508396          DOI: 10.1172/JCI119738

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Human cytomegalovirus. III. Virus-induced DNA polymerase.

Authors:  E S Huang
Journal:  J Virol       Date:  1975-08       Impact factor: 5.103

2.  Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy.

Authors:  Y F Zhou; M B Leon; M A Waclawiw; J J Popma; Z X Yu; T Finkel; S E Epstein
Journal:  N Engl J Med       Date:  1996-08-29       Impact factor: 91.245

Review 3.  Mammalian calcium-independent phospholipase A2.

Authors:  E J Ackermann; E A Dennis
Journal:  Biochim Biophys Acta       Date:  1995-11-16

4.  Molecular cloning and expression of receptor peptides that block human cytomegalovirus/cell fusion.

Authors:  B R Baldwin; M Kleinberg; S Keay
Journal:  Biochem Biophys Res Commun       Date:  1996-02-15       Impact factor: 3.575

5.  Tyrosine kinases in activation of the MAP kinase cascade by G-protein-coupled receptors.

Authors:  Y Wan; T Kurosaki; X Y Huang
Journal:  Nature       Date:  1996-04-11       Impact factor: 49.962

Review 6.  Biology of disease: free radicals and tissue injury.

Authors:  B A Freeman; J D Crapo
Journal:  Lab Invest       Date:  1982-11       Impact factor: 5.662

7.  Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection.

Authors:  E Speir; T Shibutani; Z X Yu; V Ferrans; S E Epstein
Journal:  Circ Res       Date:  1996-12       Impact factor: 17.367

8.  Calcium-mediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum.

Authors:  A R Schievella; M K Regier; W L Smith; L L Lin
Journal:  J Biol Chem       Date:  1995-12-22       Impact factor: 5.157

9.  Requirement for generation of H2O2 for platelet-derived growth factor signal transduction.

Authors:  M Sundaresan; Z X Yu; V J Ferrans; K Irani; T Finkel
Journal:  Science       Date:  1995-10-13       Impact factor: 47.728

10.  PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo.

Authors:  D R Alessi; A Cuenda; P Cohen; D T Dudley; A R Saltiel
Journal:  J Biol Chem       Date:  1995-11-17       Impact factor: 5.157

View more
  15 in total

1.  The genome of turkey herpesvirus.

Authors:  C L Afonso; E R Tulman; Z Lu; L Zsak; D L Rock; G F Kutish
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  The genome of a very virulent Marek's disease virus.

Authors:  E R Tulman; C L Afonso; Z Lu; L Zsak; D L Rock; G F Kutish
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Specific chromosome 1 breaks induced by human cytomegalovirus.

Authors:  E A Fortunato; M L Dell'Aquila; D H Spector
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

4.  Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays.

Authors:  H Zhu; J P Cong; G Mamtora; T Gingeras; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

5.  The chemokine receptor homologue encoded by US27 of human cytomegalovirus is heavily glycosylated and is present in infected human foreskin fibroblasts and enveloped virus particles.

Authors:  Barry J Margulies; Wade Gibson
Journal:  Virus Res       Date:  2006-09-08       Impact factor: 3.303

6.  Constitutive inositol phosphate formation in cytomegalovirus-infected human fibroblasts is due to expression of the chemokine receptor homologue pUS28.

Authors:  Rosalba Minisini; Calogero Tulone; Anke Lüske; Detlef Michel; Thomas Mertens; Peter Gierschik; Barbara Moepps
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

7.  Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection.

Authors:  M A Billstrom; G L Johnson; N J Avdi; G S Worthen
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 8.  Chronic viral infection and primary central nervous system malignancy.

Authors:  Robert Saddawi-Konefka; John R Crawford
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

9.  Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities.

Authors:  Maria Waldhoer; Thomas N Kledal; Helen Farrell; Thue W Schwartz
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Human cytomegalovirus carries a cell-derived phospholipase A2 required for infectivity.

Authors:  Cuider Allal; Claire Buisson-Brenac; Vincent Marion; Clotilde Claudel-Renard; Thomas Faraut; Paola Dal Monte; Daniel Streblow; Michel Record; Jean-Luc Davignon
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.